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Abstract
The aim of the research was to investigate the microbial spectre of tertiary peritonits (TP) and its antibiotic resistance as the 
way to improve the diagnostics and treatment of TP. 
Materials and methods. Prospective research enrolled 109 patients with secondary peritonitis. Tertiary peritonitis devel-
oped in 18,3 % of cases. Samples of peritoneal exudate had been drawn upon index operation, relaparotomy and on the day of diag-





mainly by Proteus  spp.  and non-albicans Candida  spp. Second-group carbapenems,  tigecycline  and piperacillin-tazobactam had 
shown the highest activity in pathogens of TP. Caspofungin proved to be the most potent antifungal agent, especially towards non-al-
bicans Candida spp. Antibiotic resistance in TP group was marked in 63,8 %.
Conclusions. Tertiary peritonitis is one of the most severe forms of abdominal sepsis with highest mortality. Causing patho-
genic flora in case of TP is mainly Gram-negative and coccal with high rates of antibiotic resistance both in vitro and in vivo. Fungi, 
presented predominantly by Candida non-albicans substrains, show an increasing content in peritoneal exudate and major effect 
upon mortality in TP. In case of TP, a significant percent of peritoneal specimens do not provide any culture growth despite of ob-
serving stringent sampling, transportation and cultivation rules. Antimicrobial therapy of TP can never be standardized and should 
always be thoroughly based upon regular and proper peritoneal and blood sampling.
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1. Introduction
Abdominal sepsis remains to be the leading problem of modern emergency surgery despite 
the global progress of surgical and pharmaceutical technologies [1, 2]. Tertiary peritonitis (TP) is 
one of the most severe forms of abdominal sepsis with dismal results of treatment, namely difficult 
verification of causal factors, mostly ineffective antibacterial treatment and, as a result, high rates 
of mortality [3, 4]. Alongside substantially impaired homeostasis, a major impact on severity of 
septic patient’s condition  is made by nosocomial microflora  [5]. For decades,  the  latter presents 
high and fast increasing resistance to a vast array of antimicrobial agents, including potent and 









department, nosology, antibiotic treatment regimen etc. [10]. Recently, an increasing role in course 
and prognosis of treatment of peritonitis is given to fungal infection [11]. All abovementioned prove 
the topicality of the problem of TP, its causing flora, antibiotic susceptibility and the need for their 
further in-depth investigation.
2. Aim of the research
The aim of the research was to investigate the microbial spectre of tertiary peritonits (TP) 
and its antibiotic resistance as the way to improve the diagnostics and treatment of TP.
3. Materials and methods
We had prospectively examined 109 patients with SP, operated in the Clinic of surgery and 
endoscopy of Lviv Danylo Halytsky national medical university in 2010–2015. 
The etiology of SP was presented by: acute destructive appendicitis (29,4 %), perforated gas-
tric (11 %) or duodenal (7,3 %) ulcer, perforated colon cancer (11 %), perforation of colonic divertic-
ulitis (6,5 %), perforation of abdominal abscess (5,6 %), acute destructive cholecystitis with perfo-
ration (4,7 %), thrombosis of superior mesenteric artery with necrosis of the small intestine (3,6 %), 
perforated gastric cancer (3,6 %), Crohn’s disease of the small intestine with perforation (3,6 %), 
hernia incarceration with necrosis of the small intestine (2,8 %), severe polytrauma with injury of 
the small bowel (2,8 %), decay of retroperitoneal tumor with formation of abscess and its perfora-
tion to abdomen (1,8 %), ingrowth of uterine tumor into small intestine and subsequent necrosis 
(0,9 %), pancreatic necrosis (0,9 %), volvulus of sigmoid colon with perforation (0,9 %), ulcerative 
colitis with necrosis of the colon (0,9 %), perforated cancer of the small bowel (0,9 %), decay of 
pancreatic cancer (0,9 %), gastric perforation by foreign body (0,9 %). 
Concomitant somatic diseases, potentially aggravating the severity of condition, were detect-




Tertiary peritonitis was diagnosed on 3rd–12th day (median – 5) in 20 (18,3 %) patients. 
Criteria for diagnosis of TP were: persistence of peritoneal symptoms despite adequate surgical 
elimination  of  the  infectious  source,  presence  of  nosocomial  microflora  in  peritoneal  exudate, 
multi-organ failure and time of stay in intensive care unit for >3 days [12]. Postoperative mortality 
in the whole cohort was 30,2 %. Tertiary peritonitis had a lethal outcome in 90 % of cases, with 
sepsis being the main cause.
Samples of peritoneal exudate had been drawn upon index operation for SP at least from 
4 distant areas in case of diffuse peritonitis and from 2 in case of local each using a separate swab 
and container with protective environment. All specimens had been transported to microbiological 
laboratory within 15 min and were cultivated using different nutritional media in appropriate ther-
mal environment. In case of programmed relaparotomy (PRL) / on-demand relaparotomy (ODRL) 
and on the day of diagnosis of TP, we had additionally performed sampling of peritoneal exudate 
directly from the peritoneal cavity and/or drainage tubes at least from 2 remote locations. 
Blood sampling was performed from both cubital veins in all patients with persistent (>48 h) 
fever, impaired consciousness (according to Glasgow scale values), prolonged (>4 days) discharge 
from drainage tubes and on the 1st day of TP diagnosis. In case blood samples gave growth to skin 
saprophytes, the sampling was repeated once again from both cubital veins. 
Actively  growing  colonies  were  identified  by  microscopy  and/or  enzyme  technique. 
Gram-positivity  and primary phenotyping of flora were evaluated by cultural  features  and bio-
chemical  identification  systems  after  24 h.  Identified  cultures  had  been  replanted  onto  Hin-
ton-Müller media to evaluate susceptibility to 19 antibiotics using Kirby-Bauer method. Suscep-
tibility  of  pathogenic  fungi  to  fluco-  and  voriconasole was  evaluated  on  glucose-enriched  agar 
using semi-quantitative method. Candida  and  its  subspecies were  identified  using mannan  and 
galactomannan serological method. 
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In majority of cases (98,4 %), initial antibacterial therapy consisted of 2 drugs with 1st either 
fluoroquinolone (3rd generation – 53 %, 4th – 47 %), cephalosporin (3rd generation – 46,3 %, 4th – 
53,7 %) or ertapenem (10,4 %); 2nd – anti-anaerobic agent (44,2 % – metronidazole, 55,8 % – orni-
dazole). Antifungal drugs were prescribed pre-emptively before initial operation to 12,2 % patients 
(fluconazole – 68,1 %, voriconazole – 31,9 %). None of  the patients had clinical signs of fungal 
infection upon admission to the hospital.
4. Results
Patients were divided into 2 groups: with SP (n=89) and with TP (n=20). In SP group, cul-
tivation  of  85,7 % of  primary  specimens  resulted  in  replantable  and  identifiable  growth,  in TP 
group – 76,2 %. As seen in Table 1, aerobic flora had quantitatively prevailed in primary specimens 
of SP. In  those patients, who developed TP further on, a shift  towards Gram-negative flora was 
marked alongside higher incidence of Candida albicans. 
Table 1
Microbial spectre of SP and TP upon index operation
Strain SP, % TP, %
Gram-positive
Staphylococcus epidermidis 45,3 43,5
Methicillin-sensitive Staphylococcus aureus 15,6 12,1
Methicillin-resistant Staphylococcus aureus 1,2 2,4
Enterococcus faecalis 28,1 26,7
Streptococcus pyogenes 32,3 36,5
Streptococcus viridans 15,6 17,2
Gram-negative
Escherichia coli 37,8 44,3
Pseudomonas aeruginosa 7,9 13,2
Citrobacter Freundii 31 28,7
Klebsiella mobilis 42,2 37,3
Klebsiella pneumoniae 4,1 5,5
Proteus vulgaris 11,9 10,1
Acinetobacter spp. 66,4 49,8
Moraxella spp. 12,5 9,7
Serratia spp. 9,8 11,2
Fungi
Candida albicans 1,7 7,6
Candida glabrata 0 6,2
Candida krusei 0 5,5
Candida tropicalis 0 1,5
Geotrichum candidum 1,1 4,7




Relaparotomy,  regardless PRL or ODRL, was  the  indication  for peritoneal exudate  sam-
pling.  In case of PRL, volume of peritoneal fluid was scarce and so were  the findings  (positive 
growth – 51,4 %): a variety of coccal flora (88,3 % of cultures), associated with E. coli (14,3 % of 
cases). In contrast, specimens taken during ODRL presented a wider (89,5 %) range of microor-
ganisms, incl. E. coli, Klebsiella spp., Proteus spp. and Enterobacter spp., associated with Candida 
albicans in 13,1 % of cases.
In 58,7 % of patients, TP was diagnosed on ODRL, in 15,4 % – on PRL. Intraoperational 
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non-albicans), 80 % died. 
Initial blood sampling was successful  in 41,2 % of SP cases,  though being false-positive 
in 9,3 %. Pathogenic flora was verified in 35,4 % cases and was presented by Streptococcus pyo-
genes (23,4 %), E. coli (10,3 %), Proteus vulgaris (34,1 %) and Acinetobacter Baumanii (32,2 %), 
not influencing the previously applied antibiotherapy. Following the development of TP, hemocul-
tures were positive in 15,1 %, presented mainly by Proteus spp. and non-albicans Candida spp.
Taking into account a multifold amount of results, antibacterial susceptibility to chosen 
drugs in SP group is given as Expected clinical efficacy (ECE) (>66 % of cultures presented de-




We had observed a substantial shift of Candida towards non-albicans subspecies, which in 
68,2 % had exposed a good susceptibility to caspofungin (26,1 %) and voriconazole (18,3 %) and a 
rather poor one to fluconazole (9,5 %). Half of the TP group received 4 antimicrobials at once incl. 1 
systemic antifungal agent.
Noteworthy peculiarities have also been marked upon analysis of ECE values depending on 














































































Antibiotic resistance to >2  antibiotics was  revealed  in 35,3 % patients  of SP group with 
prevalence of extended spectrum b-lactamase producing pathogens (Enterobacteriaceae, Pseu-
domonas aeruginosa).  In TP  group  this  parameter was  63,8 %:  2nd group carbapenem-resistant 
Acinetobacter baumanii (61,3 % of cultures), methicillin-resistant Staphylococcus aureus (32,1 %), 
fluconasole-resistant Candida albicans (58,3 %). In general, multi-drug resistant (MDR) pathogens 
comprised 28,7 % of cases in TP group and were represented mainly by Acinetobacter spp. and 
Klebsiella spp. with highest (39,8 %) sensitivity to doripenem.









ECE depending on Gram-polarity (% of sensitive cultures)
Antibacterial drug Gram-positive Gram-negativeSP TP SP TP
doripenem 80 68 92 81
imipenem / cilastatin 76 65 84 76
meronem 78 63 80 69
ertapenem 60 41 70 37
tigecycline 64 58 69 58
piperacillin-tazobactam 75 62 30 21
moxifloxacin 86 74 48 39
levofloxacin 50 59 65 48
amikacin 57 38 62 54
cefepime 30 42 55 31
ceftazidime 68 50 34 15
linezolid 50 41 11 10
teicoplanin 51 32 9 8
clindamycin 50 28 13 5
vancomycin 45 43 45 2
gentamicin 24 19 40 17
Table 4
Characteristics of antimicrobial treatment in both groups
Type of antibiotic treatment SP TP
de-escalation 14,3 % 0 %
escalation 4,7 % 100 %
combined
85,6 % 93,3 % – 2 agents,  6,7 % – 3 agents 100 %
73,1 % – 2 agents,  
16,6 % – 3 agents,  
10,3 % – 4 agents
definitive 44,5 % 30 %
It is worth of mentioning that several substrains of Staphylococci (TP group) demonstrated 
medium (33–66 %) susceptibility to fosfomycin. As well, we observed >66 % in vitro efficacy of 
co-trimoxazole towards certain strains of Acinetobacter spp. and Citrobacter spp. Similar in vitro 
data were obtained about activity of colistin towards P. aeruginosa and E. coli. Although, none of 
those were chosen for use in vivo due to known significant side effects, particularly toxicity and 
risk of further promotion of antibiotic resistance.
5. Discussion
Tertiary peritonitis was once called an “uncontrolled peritonitis”, manifesting itself as sep-
sis at the background of sterile peritoneum [13]. Hospital-acquired infections, concomitant diseases 
and immunosuppression are one of the most potent risk factors of mortality [14]. Failure of anti-
bacterial therapy is considered to be one of the indications for hemoculturing, as Candida spp. are 
often suspected [9]. Severity of condition, causal pathogenic flora and prognosis differ substantially 
in septic patients of surgical department and ICU [15]. 
According to a recent study of O. van Ruler et al. [16], 70 % of peritoneal cultures of SP were 
polymicrobial, 19 % – monomicrobial and 11 % showed no microbial growth. Another group of 
authors observed 72 % cases of polymicrobial, 8–28 % monomicrobial cultures and up to 20 % of 
unsuccessful microbial sampling [17, 18]. These data partially coincide with ours, though percent-
ages in TP group differ essentially.
Recent studies of microbial spectre of SP prove that  it  is mostly stable  throughout years: 
E. coli – 50–100 %, Streptococcus spp. – 10–44 %, P. aeruginosa – 24,9 %, S. aureus – 16 % 
[19]. Severity of the patient’s condition and difficulties of adequate “source control” upon index 









of modern works indicate on lower incidence of successful peritoneal sampling, a move towards 
Gram-positive flora and increasing content of fungi [21]. One study observed E. coli in 52 % culti-
vates of TP, Klebsiella spp. – 10 %, Enterobacter spp. – 19 %, P. aeruginosa 13 %, Enterococcus 
faecalis – 33 %, Enterococcus faecium – 8 % [22]. These findings also have similarities with our 
research, though, study duration could have led to changes both in spectre and antibiotic suscepti-
bility over time. Diversities and sometimes discrepancies in microbial spectres of peritonites could 
be explained by differences in regional protocols/standards of antibiotic treatment and structure of 
morbidity of given population.
Yeast strains comprise 22–41 % in exudate of SP and 17 % of all nosocomial  isolates  in 
ICU [23]. Isolation of Candida from intra-abdominal cultures is successful in 57 % of cases and 
is associated with increased mortality [24]. In the structure of obtained fungal cultures during SP, 
Candida albicans was seen in 74 %, Candida glabrata – 17 %; remaining 9 % included: Candida 
inconspicua, Candida parapsilosis, Candida tropicalis, Candida zeylanoides, Geotrichum can-
didum [23]. In our research, in SP group we observed lesser percentage of Candida albicans and 
very moderate – of Candida non-albicans in comparison to TP group.
Prevalence of Candida, especially of its non-albicans strains, in peritoneal exudate on index 
operation hints upon compromised anti-infective defense and latent immunodeficiency as potent 
risk factors for development of TP. In case of candidous TP, mortality reaches 70 % [11]. Perito-
neal sampling during TP had shown positive culturing of albicans-subspecies in 12 % of cases, 
non-albicans-subspecies – in 3 % [23]. In TP group, we had seen a remarkable shift of the ratio of 
“albicans/non-albicans” subspecies in favour of the latter. 
Blood culture is a necessary method to control the spread of the infection to the system-
ic level. According to reports, it’s successful in 9,2–21,2 % [25, 26]. Results of hemocultivation 
differ as well, probably depending on patient’s general health condition, severity of surgical dis-
ease, characteristics of therapy and accuracy of cultivation. Leading Gram-positive pathogens in 
blood culture are Staphylococcus spp. (48,7 %) and Enterococcus spp. (12,8 %) [10]. Gram-negative 
pathogens were obtained from 25,7 % specimens and included Klebsiella pneumoniae (12,8 %), En-
terobacter cloacae (2,6 %), E. coli (2,6 %), Proteus vulgaris (2,6 %); others (7,7 %) were: P. aeru-
ginosa (2,6 %), Acinetobacter baumannii (2,6 %) and Candida (2,6 %) [10]. In our study, mostly 
Gram-positive coccal flora was found in blood of patients of SP group and only 2 pathogens in TP 
group, notably, non-albicans Candida spp. 
International research data claim a vast range of hemocultivation of Candida spp. – 4–32 % 
[27]. Regardless of primary disease, Hung-Wei C. et al. [28] reported a shift from Candida albicans 
to Candida non-albicans subspecies in hemocultures, with non-albicans quotient equaling up to 
63 %. Out results of hemocultivation in TP group were 90 % of non-albicans substrains.
Clinicians still deal with unclear previous history of antibiotic use and fungal status, which 




inadequate antimicrobial therapy is the risk factor for pessimistic outcome [21].
Antimicrobial susceptibility data vary a lot due to the huge set of independent factors, in-
cluding technique of sampling, quality of nutritional media, subjectivity of interpretation and actu-
al antimicrobial protocols. In our study, 2nd group carbapenems showed the highest in vitro efficacy 
in both study groups, corresponding to data of other colleagues [29]. Other clinicians call to dimin-
ish/ignore the use of any generation cephalosporins due to serious drop of their efficacy with time 
and strong promotion of antibacterial resistance [26].
On one hand, antifungal therapy should be prescribed either to each critical patient or in 
case of positive fungal culture [8], on the other – empiric coverage of yeast in abdominal sepsis is 
not supported by present data because of high resistance of Candida spp. to fluconasole [27].
Finally,  the “collateral damage” effect,  alongside natural process of antibiotic  resistance, 
became the main reason of emergence of MDR pathogens. Antibiotic resistance to >2 antibiotics 
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depth investigation of its microbial spectre and antibiotic resistance in order to improve the ap-
proach to diagnostics and treatment results.
6. Conclusions
1. Tertiary peritonitis remains to be one of the most severe forms of abdominal sepsis with 
highest mortality. 
2. Causing pathogenic flora in case of tertiary peritonitis is mainly Gram-negative and coc-
cal with high rates of antibiotic resistance both in vitro and in vivo.
3. Fungi, presented predominantly by Candida non-albicans substrains, show an increasing 
content in peritoneal exudate and major effect upon mortality in tertiary peritonitis.
4. In case of tertiary peritonitis, a significant percent of peritoneal specimens do not provide 
any culture growth despite of observing stringent sampling, transportation and cultivation rules.
5. Antimicrobial therapy of tertiary peritonitis can never be standardized and should always 
be thoroughly based upon regular and proper peritoneal and blood sampling.
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